Phospho-CD22 (Y807) Polyclonal Antibody, 100ul Cell Transfection Additional splice variation has been

Additional splice variation has been identified but the full-length nature of these transcripts has not been determined

finished products are authoritatively tested by third-party testing institutions

eliminating the need to send the device for third-party calibration

which can lead to early-onset insulin-dependent diabetes mellitus (NIDDM)

Interacts with UBL1/SUMO-1

Phospho-CD22 (Y807) Polyclonal Antibody, 100ul Cell Transfection Additional splice variation has beenCD22, also known as Siglec 2 (sialic acid binding Ig like lectin 2) or BL CAM (B lymphocyte cell adhesion molecule), is a 130 140 kDa, B cell restricted, type I transmembrane glycoprotein belonging to the immunoglobulin gene superfamily. The expression of CD22 is developmentally regulated. It is expressed at low levels in the cytoplasm of pro B and pre B cells and present on the cell surface only at mature stages of B cell differentiation. Cell